A New Age of Medicine
AI-Powered Drug Improvement for Faster, Smarter Therapeutic Innovation
Pharma R1 brings together advanced AI, expert scientific insight, and a high-velocity development engine to improve existing drugs at scale—unlocking safer, more effective therapies faster than traditional R&D could ever achieve.
Lower-Risk, Faster-to-Market Drug Innovation
Pharma R1 addresses the growing challenge of costly, slow drug development by focusing on smarter pathways to therapeutic advancement. Our strategy increases the likelihood of success and shortens development timelines through better asset selection and prioritized advancement. By evaluating hundreds opportunities in parallel, we create a scalable model that brings high-value therapeutic improvements forward with greater confidence and speed.
OUR PILLARS OF INNOVATION
How We Scale, Strengthen, and Accelerate Drug Improvement
AI-Driven Discovery at Scale
Our platform analyzes massive biological and clinical datasets to uncover therapeutic opportunities that conventional research often overlooks. This broad intelligence gives us stronger starting points for drug improvement.
Expert Validation and De-Risking
Every potential improvement goes through scientific, clinical, regulatory, and IP review, supported by targeted experimental testing. This rigorous process ensures that only the most promising and practical ideas advance.
Industrial-Scale Advancement
Pharma R1 progresses hundreds of drug assets in parallel through a streamlined workflow that builds on known safety and efficacy data. This model increases the number of viable candidates ready for partnership and progression.
THE INTELLIGENT DISCOVERY ENGINE
We are not chasing targets. We are reprogramming how discovery works.
Translating AI-Driven Insights Into Real Therapeutic Progress
VivaMed BioPharma is the development engine of our platform, taking AI-prioritized drug improvement concepts through focused scientific validation, safety assessment, and regulatory alignment. By advancing only the strongest opportunities, VivaMed helps convert early AI insights into improved therapeutic candidates ready for partnership or progression.
A Unified Map of Human Biology
BioAtlas integrates more than 40 global biomedical datasets into one harmonized engine that maps genes, diseases, pathways, perturbations, and drug signatures. It allows our AI models to understand human biology with unmatched depth and context, revealing connections that traditional research workflows never surface.
Mechanism-First Intelligence for Precision Discovery
VivaOS reclassifies 15,000 diseases into mechanistic endotypes and ranks treatment options using millions of data points. It recovers most standard-of-care therapies and identifies new opportunities by understanding biology at the pathway and systems level. This engine gives Pharma R1 its predictive power and sets the foundation for AI-driven drug improvement.
A Collaborative Platform for Turning Concepts Into Candidates
VivaMed BioVentures is an innovation marketplace that brings together internal scientists, external researchers, and citizen modelers. It allows vetted drug improvement concepts to be submitted, ranked, refined, and surfaced to pharma partners. The platform expands our discovery reach and accelerates the path from idea to validated therapeutic opportunity.
Breakthrough Innovation Happens Together
At Pharma R1, collaboration is fundamental to how we discover, validate, and advance improved therapies. Our network spans leading CROs, research universities, clinicians, and technology partners who help validate AI insights and accelerate the transition from concept to candidate. Together we identify high-value opportunities earlier, de-risk development, and bring better therapies forward with greater speed.
- Global CRO partnerships for rapid validation
- Collaborations with university and research institutions
- Access to AI-prioritized drug improvement candidates
MOMENTUM
Proven Execution Across AI, Drug Development, and Strategic Partnerships
Our leadership team brings decades of combined experience across biotechnology, AI, clinical development, regulatory strategy, and commercialization. Through VivaMed BioPharma and our broader ecosystem, we have built and validated drug assets, supported regulatory approvals, and advanced therapies across multiple continents. Pharma R1 extends this foundation with a platform that moves smarter and faster, supported by global partners and a team with a track record of real results.
- 150+ drug assets advanced through our platform ecosystems
- 39 regulatory approvals supported by our team
- Operations and partnerships across 5 countries
TEAM
From AI Platforms to Biotech Exits, We’ve Built This Future Before
Pharma R1 is powered by the same leadership team behind VivaMed BioPharma. Our backgrounds span clinical research, drug repurposing, regulatory strategy, product development, and operational execution. We have launched biotech companies, secured drug approvals, scaled platforms, and guided successful exits. Now we are applying that experience to redefine how improved therapies reach the market and deliver real impact for patients.
Global. Agile. Mission-focused.
We are here to build therapies that matter.
40+
Years as healthcare entrepreneurs and innovators
25+
Years partnering with research universities, CROs, and private equity
CONTACT
Let's Connect
Have a question, opportunity, or idea? Whether you’re a researcher, investor, or potential partner—we’d love to hear from you.